TScan Therapeutics, Inc. (TCRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -24.28M | -32M | -32.46M | -33.27M | -37.59M | -27.41M | -27.92M | -26.23M | -29.27M | -23.77M | 8.02M | -22.02M | -23.59M | -16.01M | -17M | -13.37M | -20.12M | -14.38M | -13.64M | -10.7M |
| Operating CF Margin % | -2472.4% | -1246.67% | -1292.87% | -1081.5% | -1731.28% | -4122.11% | -2661.39% | -4892.72% | -5170.85% | -329.58% | 206.25% | -699.56% | -346.71% | -517.29% | -505.56% | -329.56% | -666.14% | -503.85% | -565.51% | -375.7% |
| Operating CF Growth % | 35.4% | -16.74% | -16.28% | -26.85% | -28.42% | -15.34% | -448.24% | -19.09% | -24.08% | -48.44% | 147.15% | -64.75% | -17.21% | -11.34% | -24.65% | -24.93% | -102.11% | -95.65% | - | - |
| Net Income | -28.67M | -22.98M | -35.71M | -36.95M | -34.13M | -35.81M | -29.89M | -31.66M | -30.14M | -19.61M | -23M | -24.05M | -22.56M | -18.72M | -16.25M | -15.1M | -16.16M | -14.2M | -15.84M | -10.67M |
| Depreciation & Amortization | 693K | 723K | 767K | 698K | 678K | 711K | 1.03M | 1.12M | 1.25M | 1.28M | 1.29M | 1.3M | 1.5M | 1.48M | 1.25M | 1.21M | 1.2M | 1.14M | 1.06M | 661K |
| Stock-Based Compensation | 0 | 2.01M | 3.01M | 3.27M | 3.41M | 2.71M | 2.52M | 2.33M | 1.98M | 1.5M | 1.34M | 1.22M | 1.15M | 1.3M | 1.25M | 1.02M | 0 | 784K | 885K | 503K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.58M | 65K | -173K | -672K | -1.17M | -287K | -1.3M | -191K | -254K | -735K | -12K | 218K | 214K | 216K | 44K | 0 | 984K | 0 | 0 | 0 |
| Working Capital Changes | 1.11M | -11.82M | -359K | 386K | -6.38M | 5.26M | -279K | 2.18M | -2.11M | -6.2M | 28.4M | -711K | -3.88M | -284K | -3.3M | -501K | -6.15M | -2.11M | 258K | -1.19M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.04M | -5.07M | 1.93M | -435K | 558K | 983K | 1.02M | 396K | -410K | -641K | -273K | 367K | 495K | 414K | -1.12M | 408K | 824K | -2.46M | 879K | 1.43M |
| Cash from Investing | -70K | 14.83M | 32.58M | 48.44M | 13.53M | 27.29M | -82.35M | -33.72M | 36.16M | 1.91M | -61.41M | -420K | -838K | -1.38M | -424K | -1.89M | -531K | -2.21M | -853K | -3.92M |
| Capital Expenditures | -70K | -171K | -1.43M | -1.28M | -1.53M | -888K | -1.37M | -862K | -705K | -469K | -1.42M | -420K | -838K | -1.38M | -424K | -1.89M | -531K | -2.21M | -853K | -3.92M |
| CapEx % of Revenue | 7.13% | 6.66% | 56.75% | 41.58% | 70.57% | 133.53% | 130.6% | 160.82% | 124.56% | 6.5% | 36.51% | 13.34% | 12.32% | 44.49% | 12.61% | 46.67% | 17.58% | 77.47% | 35.36% | 137.57% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 73K | 0 | 116K | -525K | 45.69M | 1.23M | 161.59M | 258K | 19K | -252K | 135.68M | 0 | 108K | 29.13M | 31K | 88K | 120K | 90.61M | -686K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 15.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.12M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 73K | 0 | 191K | 0 | 30.38M | 1.23M | 0 | 0 | 0 | -186K | 0 | 0 | 193K | 5K | 31K | 88K | 120K | 89.65M | 62K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 191K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -75K | -525K | 0 | 0 | 161.59M | 258K | 19K | -66K | 135.68M | 0 | -85K | 0 | 0 | 0 | 0 | 960K | -748K |
| Net Change in Cash | -24.35M | -17.1M | 112K | 15.29M | -24.58M | 45.57M | -109.04M | 101.65M | 7.15M | -21.83M | -53.65M | 113.23M | -24.43M | -17.28M | 11.7M | -15.23M | -20.57M | -20.91M | 76.11M | -15.3M |
| Free Cash Flow | -24.35M | -32.17M | -33.89M | -34.55M | -39.12M | -28.3M | -29.29M | -27.09M | -29.97M | -24.23M | 6.6M | -22.44M | -24.43M | -17.39M | -17.43M | -15.26M | -20.66M | -16.59M | -14.49M | -14.62M |
| FCF Margin % | -2479.53% | -1253.33% | -1349.62% | -1123.08% | -1801.84% | -4255.64% | -2791.99% | -5053.54% | -5295.41% | -336.08% | 169.75% | -712.9% | -359.03% | -561.78% | -518.17% | -376.23% | -683.71% | -581.32% | -600.87% | -513.27% |
| FCF Growth % | 37.76% | -13.69% | -15.71% | -27.54% | -30.52% | -16.77% | -543.89% | -20.7% | -22.71% | -39.39% | 137.86% | -47.06% | -18.25% | -4.8% | -20.24% | -4.39% | -59.92% | -89.94% | - | - |
| FCF per Share | -0.19 | -0.25 | -0.26 | -0.27 | -0.30 | -0.23 | -0.25 | -0.24 | -0.32 | -0.26 | 0.07 | -0.48 | -1.01 | -0.72 | -0.72 | -0.63 | -0.86 | -0.69 | -0.61 | -0.61 |
| FCF Conversion (FCF/Net Income) | 0.85x | 1.39x | 0.91x | 0.90x | 1.10x | 0.77x | 0.93x | 0.83x | 0.97x | 1.21x | -0.35x | 0.92x | 1.05x | 0.86x | 1.05x | 0.89x | 1.25x | 1.01x | 0.86x | 1.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 569K | 612K | 759K | 752K | 758K | 741K | 759K | 759K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |